Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at fordelene ved Focetria opvejer risiciene til forebyggelse af influenza ved en officielt erklæret pandemisk situation.
The Committee for Medicinal Products for Human Use (CHMP) decided that Focetria’ s benefits are greater than its risks for the prophylaxis of influenza in an officially declared pandemic situation.